RMBS Stock Analysis: Rambus | NASDAQ
Semiconductors | NASDAQ, USA | Market Cap: 9.100m USD | 12M Return: -24% | US7509171069 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 132M
EPS Trend: -6.7%
Qual. Beats: 2
Rev. Trend: 99.0%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Rambus Inc. (NASDAQ: RMBS) is a U.S.-based semiconductor company headquartered in San Jose, California, operating across the United States, South Korea, Singapore, and other international markets. The company operates in two main segments: (1) memory interface chips, including DDR5 and DDR4 products such as registering clock drivers, data buffers, power management ICs, and temperature sensors; and (2) silicon IP, offering interface and security IP solutions for AI, data center, government, and automotive applications, alongside a portfolio of patents covering memory architecture and high-speed serial links. Rambus sells to memory module manufacturers, OEMs, hyperscalers, and chip makers through a direct sales force and distributors.
The company is classified within the Information Technology sector under the Semiconductors sub-industry and has been publicly traded since its 1997 IPO. As a fabless semiconductor company, Rambus focuses on chip design and IP licensing rather than operating its own fabrication facilities, a common business model in the industry that allows it to scale R&D investment while outsourcing manufacturing to third-party foundries.
- DDR5 memory interface chip shipments accelerate with server refresh cycle
- Silicon IP revenue grows on AI data center security demand
- Patent licensing royalties face ongoing disputes and renegotiation pressure
| Net Income: 265.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.20 > 0.02 and ΔFCF/TA -0.71 > 1.0 |
| NWC/Revenue: 118.0% < 20% (prev 117.0%; Δ 0.98% < -1%) |
| CFO/TA 0.22 > 3% & CFO 346.8m > Net Income 265.9m |
| Net Debt (-756.7m) to EBITDA (362.0m): -2.09 < 3 |
| Current Ratio: 9.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (108.8m) vs 12m ago -0.16% < -2% |
| Gross Margin: 79.14% > 18% (prev 75.75%; Δ 3.38% > 0.5%) |
| Asset Turnover: 53.71% > 50% (prev 48.24%; Δ 5.46% > 0%) |
| Interest Coverage Ratio: 268.7 > 6 (EBIT TTM 317.0m / Interest Expense TTM 1.18m) |
| A: 0.60 (Total Current Assets 1.05b - Total Current Liabilities 112.1m) / Total Assets 1.56b |
| B: 0.18 (Retained Earnings 278.8m / Total Assets 1.56b) |
| C: 0.21 (EBIT TTM 317.0m / Avg Total Assets 1.48b) |
| D: 10.09 (Book Value of Equity 1.42b / Total Liabilities 140.5m) |
| Altman-Z'' = 16.57 = AAA |
| DSRI: 1.10 (Receivables 169.0m/131.3m, Revenue 796.1m/678.5m) |
| GMI: 0.96 (GM 75.75% / 79.14%) |
| AQI: 0.83 (AQ_t 0.25 / AQ_t-1 0.30) |
| SGI: 1.17 (Revenue 796.1m / 678.5m) |
| TATA: -0.05 (NI 265.9m - CFO 346.8m) / TA 1.56b) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of November 21, 2026, the stock is trading at USD 66.35 with a total of 2,413,385 shares traded. Over the past week, the price has changed by -19.31%, over one month by -28.21%, over three months by -28.00% and over the past year by -23.98%.
Current recommended Stop Loss: 59.10 (which is 10.9% or 1.2 ATR below the current price).
Rambus has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy RMBS.
- StrongBuy: 6
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 140.6 | 111.9% |
P/E Trailing = 35.2573
P/E Forward = 24.1546
P/S = 11.4306
P/B = 6.4481
P/EG = 3.8007
Revenue TTM = 796.1m USD
EBIT TTM = 317.0m USD
EBITDA TTM = 362.0m USD
Long Term Debt = 14.6m USD (estimated: total debt 20.2m - short term 5.64m)
Short Term Debt = 5.64m USD (from shortTermDebt, last quarter)
Debt = 20.2m USD (from shortLongTermDebtTotal, last quarter) (leases 20.2m already included)
Net Debt = -756.7m USD (calculated: Debt 20.2m - CCE 776.9m)
Enterprise Value = 8.34b USD (9.10b + Debt 20.2m - CCE 776.9m)
Interest Coverage Ratio = 268.7 (Ebit TTM 317.0m / Interest Expense TTM 1.18m)
EV/FCF = 26.66x (Enterprise Value 8.34b / FCF TTM 312.9m)
FCF Yield = 3.75% (FCF TTM 312.9m / Enterprise Value 8.34b)
FCF Margin = 39.31% (FCF TTM 312.9m / Revenue TTM 796.1m)
Net Margin = 33.40% (Net Income TTM 265.9m / Revenue TTM 796.1m)
Gross Margin = 79.14% ((Revenue TTM 796.1m - Cost of Revenue TTM 166.1m) / Revenue TTM)
Gross Margin QoQ = 78.30% (prev 79.76%)
Tobins Q-Ratio = 5.35 (Enterprise Value 8.34b / Total Assets 1.56b)
Interest Expense / Debt = 5.84% (Interest Expense 1.18m / Debt 20.2m)
Taxrate = 15.83% (50.0m / 315.9m)
NOPAT = 266.9m (EBIT 317.0m * (1 - 15.83%))
Current Ratio = 9.38 (Total Current Assets 1.05b / Total Current Liabilities 112.1m)
Debt / Equity = 0.01 (Debt 20.2m / totalStockholderEquity, last quarter 1.42b)
Debt / EBITDA = -2.09 (Net Debt -756.7m / EBITDA 362.0m)
Debt / FCF = -2.42 (Net Debt -756.7m / FCF TTM 312.9m)
Total Stockholder Equity = 1.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.94% (Net Income 265.9m / Total Assets 1.56b)
RoE = 18.85% (Net Income TTM 265.9m / Total Stockholder Equity 1.41b)
RoCE = 22.25% (EBIT 317.0m / Capital Employed (Equity 1.41b + L.T.Debt 14.6m))
RoIC = 18.90% (NOPAT 266.9m / Invested Capital 1.41b)
WACC = 15.93% (E(9.10b)/V(9.12b) * Re(15.95%) + D(20.2m)/V(9.12b) * Rd(5.84%) * (1-Tc(0.16)))
Discount Rate = 15.95% (= CAPM, Blume Beta Adj.) -> capped to 12.54%
Shares (quarterly) Correlation: 52.11 | Cagr: -0.11%
[DCF] Terminal Value 54.86% ; FCFF base≈304.7m ; Y1≈323.8m ; Y5≈384.1m
[DCF] Fair Price = 30.91 (EV 2.55b - Net Debt -756.7m = Equity 3.31b / Shares 107.1m; r=15.93% [WACC]; 5y FCF grow 7.03% → 2.50% )
EPS Correlation: -6.71 | EPS CAGR: -1.03% | SUE: 0.84 | # QB: 2
Revenue Correlation: 98.99 | Revenue CAGR: 24.18% | SUE: 0.58 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.88 | Chg30d=+3.73% | Revisions=+44% | Analysts=6
EPS current Year (2026-12-31): EPS=3.11 | Chg30d=+2.41% | Revisions=+50% | GrowthEPS=+26.6% | GrowthRev=+18.8%
EPS next Year (2027-12-31): EPS=3.88 | Chg30d=+4.40% | Revisions=+50% | GrowthEPS=+25.0% | GrowthRev=+20.5%
[Analyst] Revisions Ratio: +61% (up=17, down=3)